Purpose: To review and describe in detail the demographics, functional and anatomical characteristics, and clinical course of pigmented paravenous chorioretinal atrophy in a large cohort of adults and children.
P
igmented paravenous chorioretinal atrophy (PPCRA) is a rare form of chorioretinal atrophy in which there is bilateral paravenous retinal pigment epithelial atrophy and pigment clumping. 1 It was first termed retinochoroiditis radiata in 1937. 2 Since then a limited number of small case series have been published. 1, [3] [4] [5] [6] [7] It has been reported to be more common in males, most published cases are sporadic, and it is usually diagnosed on routine examination in asymptomatic patients. 8, 9 Vision is generally normal or mildly reduced at presentation, with minimal to no progression described over time. 5 Diagnosis is based on the characteristic appearance on fundus examination, although detailed retinal imaging and retinal electrophysiology are helpful in confirming the diagnosis. 8 Electroretinography (ERG) shows a spectrum of abnormalities and in contrast to most inherited retinal dystrophies often shows marked interocular asymmetry.
There are several hypotheses regarding the cause, with uncertainty about whether this has a genetic or inflammatory/infectious etiology. There is only rarely a family history, but there has been one report of a heterozygous CRB1 mutation of uncertain significance identified in a family with apparently dominantly inherited PPCRA with variable expressivity. 10 Perivascular atrophy has also been described in autosomal dominant retinitis pigmentosa (RP) associated with mutations in the TOPORS gene, but the retinal appearance is atypical for PPCRA. 11 By contrast, in one report, the monozygotic twin of an affected adult was unaffected, suggesting that at least some cases are nongenetic. 12 Given the limited descriptions of small case series in the literature to date, there is a need to improve our knowledge of this rare disease. Our study reviews the functional and anatomical characteristics of PPCRA in the largest cohort to date seen at a single center, with the aim of providing a detailed description of demographics, presentation, associations, phenotype, and natural history of PPCRA.
Methods
The study adhered to the tenets of the Declaration of Helsinki and was approved by the Moorfields Eye Hospital ethics committee. We retrospectively reviewed records of patients diagnosed with PPCRA at Moorfields Eye Hospital between 1974 and 2016. The diagnosis of PPCRA was based on the presence of a characteristic fundus appearance of chorioretinal atrophy with variable pigmentation along the retinal veins in one or both eyes.
The clinical data reviewed included age at onset, ethnicity, sex, presence of symptoms, duration of follow-up, previous ocular inflammation, family history of inherited eye disease, visual acuity, color vision, color fundus photography, fundus autofluorescence (FAF) imaging, optical coherence tomography (OCT), and electrophysiological assessment.
The age at onset was defined as the age at which the retinal changes were first noted. Duration of the disease was defined as the difference between the age at onset and the most recent examination. Bestcorrected vision was measured using the Snellen visual acuity chart. Color vision was assessed using Ishihara pseudoisochromatic plates.
Fundus photographs were obtained with either a TRC-50LA Retinal fundus camera (Topcon, Tokyo, Japan) or Optos wide-field camera (Optos Panoramic 200; Optos PLC, Dunfermline, Scotland, United Kingdom). Fundus autofluorescence images were obtained with either Spectralis HRA OCT; (Heidelberg Engineering, Heidelberg, Germany) or Optos wide-field camera. Retinal lamination and central retinal thickness was evaluated using the Spectralis HRA OCT (Heidelberg Engineering). Eighteen of 23 patients underwent ERG testing. Full-field and pattern ERG (PERG) were performed in most with gold foil recording electrodes. Additional multifocal ERG (mfERG) and electrooculogram (EOG) were performed in some. The electrophysiology incorporated the ISCEV (International Society for Clinical Electrophysiology of Vision) standard protocols [13] [14] [15] [16] [17] except in one young patient who underwent ERG testing with skin electrodes without mydriasis using a previously reported protocol. 17 
Results
Twenty-three patients; 10 females and 13 males with the diagnosis of PPCRA were identified. The ethnic background was diverse with 15 white (66%), 4 Asian (18%), 1 Turkish (4%), 1 Colombian (4%), 1 Nigerian (4%), and 1 Chinese (4%) patient. Mean age at onset was 36.6 years (range 10-67 years). The mean follow-up period was 5.3 years (range 0-30 years)-with 2 patients only attending a single visit. General clinical, structural, and functional characteristics of the entire cohort are described below (summarized in  Tables 1-3 , with representative imaging and electrophysiology in Figures 1 and 2 There was no family history of inherited eye disease in 22/23 (96%). One patient (Pt 13), who had been diagnosed as having RP by the referring physician, had Thirteen (57%) patients were asymptomatic. In patients who were symptomatic, the presenting symptoms included photopsia (n = 1.4%), blurred vision (n = 4.17%), peripheral visual field loss (n = 3.13%), and nyctalopia (n = 2.9%). Most patients had no refractive error noted (n = 17.74%), with myopia in five of six patients with refractive error.
At baseline, 78% (n = 18/23) of patients had visual acuity of $6/12 in each eye; and at final follow-up $6/12 in 71% (n = 15/21) patients in the right eye and 86% (n = 18/21) in the left eye (Table 1) . Color vision was normal in the 14 patients who had this assessed. Color fundus photographs were available for 22 patients and FAF imaging for 20 patients at baseline. Retinal changes were asymmetrical in 16 (76%) of the 21 patients who had PPCRA in both eyes.
Selected Representative Patients
Case 1. A 10-year-old boy was referred by his optician who noted retinal pigmentation on routine assessment. He was visually asymptomatic with a visual acuity of 6/5 in each eye. Retinal examination, retinal imaging, and perimetry revealed highly asymmetrical retinal findings in keeping with PPCRA, with normal macula and disks (Figure 1 ). Full-field ERGs were asymmetrical, consistent with generalized rod and cone photoreceptor dysfunction on the right and a mild loss of rod photoreceptor function on the left. There was no PERG evidence of macular dysfunction in either eye. Visual acuity, retinal appearance, imaging, and perimetry were all stable with no evidence of progression in either eye 4 years later.
Case 4. At 4 years of age, 3 weeks after MMR immunization, he developed a flu-like illness, skin rash, and reduced vision. Information from his referring physician indicated bilateral retinal edema and abnormal visual evoked potentials and ERG, with a suspected coexisting optic neuritis. Magnetic resonant imaging of the brain was normal. Retinal edema settled after treatment with intravenous steroids, but he was noted to have developed a pigmented paravenous retinopathy 3 years later. He reported no deterioration 
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RETINA, THE JOURNAL OF RETINAL AND VITREOUS DISEASES 2019 VOLUME 39 NUMBER 3 (Figure 1 ). Optical coherence tomography scans were normal and FAF imaging showed areas of reduced signal corresponding to the areas of retinal pigmentation (Figure 1 ). There was ERG evidence of generalized retinal dysfunction affecting rod more than cone systems bilaterally, at the level of the photoreceptors and additionally at a level that is postphototransduction or inner retinal. Pattern ERGs were consistent with macular involvement bilaterally. At 12 months, vision and retinal imaging were stable. Esterman binocular visual field testing identified only two missed test areas in the tested field of 120°. Furthermore, no significant scotoma within or encroaching the central 20°were seen as shown in Supplemental Digital Content 5 (see Figure 5 , http://links.lww.com/IAE/A791, bottom row).
Case 11. This 70-year-old man was diagnosed with RP by his local ophthalmologist 41 years before presentation 10 years ago. He had longstanding symptoms of loss of peripheral vision. He was unable to take his driving test because he failed to read the number plate at the required distance. He described problems with night vision. He retained good central vision until 3 years before presentation. There was no family history of visual problems. His four children and grandchildren were asymptomatic. His visual acuity was 6/60 in the right eye and hand motion in the left eye. There was bone spicule pigmentation around the blood vessels in both eyes and atrophic changes around the disks (Figure 2 ). There were areas of atrophy in the right macula. Three years later, new small intraretinal cysts at the fovea in the right eye were noted which resolved without treatment (Figure 2 ).
Case 15. Twenty-one-year-old woman presented with symptoms of photopsia and floaters which subsided over a short period. She reported no symptoms of night blindness. At the age of 11 years, she was diagnosed elsewhere with a retinal dystrophy but has maintained stable vision. There was no family history of inherited eye disease. Perivascular pigment clumping radiating from the optic disks was evident in both 
Fundus Autofluorescence Pattern
We identified four principal patterns of FAF: Optical coherence tomography imaging of PPCRAassociated lesions was available in two patients (see (see Figure 5 , http://links.lww.com/IAE/A791). Fullfield ERGs were abnormal in 18 cases (Table 3 and Figure 2 ), consistent with generalized retinal dysfunction; these included 5 with bilaterally abnormal but markedly asymmetrical ERGs (Cases 1, 3, 7, 8 , and 12), 2 with unilateral retinal dysfunction (asymmetrical) (Cases 16 and 22) , and a further 2 with borderline ERG parameters in the better eye (Cases 2 and 19) . The interocular asymmetries in the main ERG parameters are highlighted in Supplemental Digital Content 5 (see Figure 5B , http://links.lww.com/IAE/A791). Comparison of dark-adapted (DA) and light-adapted (LA) ERGs showed a similar degree of generalized rod and cone system dysfunction in most cases, but five eyes of three individuals showed ERG evidence of slightly greater rod than cone system involvement. There was evidence of both photoreceptor dysfunction (DA10 ERG a-wave reduction) and additional dysfunction occurring postphototransduction or at the level of the inner retinal (b-wave reduction relative to the a-wave) in six eyes of four individuals, and in 1 (Case 21), there was evidence of generalized On-bipolar cell dysfunction of both rod and cone systems, with preservation of photoreceptor function bilaterally. Most cases showed delay in the 30-Hz flicker (LA 30 Hz) ERG, asymmetrical (3 ms or more difference) in 5 cases (Figure 2 and see Figure 5A , Supplemental Digital Content 5, http://links.lww.com/IAE/A791), and generally most delayed in those with the worst amplitude reduction. In the 2 patients with unilateral PPCRA, ERGs were normal in the other eye of Case 17 and borderline in the other eye of Case 16. The EOG light peak to dark trough ratio was abnormal in 8 of 12 eyes tested and was borderline in one other eye; in no case was the reduction disproportionate to DA 10 ERG a-wave reduction.
Nine of 17 patients had PERG P50 reduction consistent with bilateral macular dysfunction and a further 2 had unilateral P50 reduction (amplitude subnormal or significantly asymmetrical). In 3 cases (5 eyes), additional mfERGs indicated reduced responses that were most severe over paracentral areas. The severity of PERG reduction was not directly related to full-field ERG parameters; PERGs were normal in 12 eyes with moderately severe to severe generalized retinal dysfunction, and were significantly subnormal in 6 eyes of 3 subjects with normal or near-normal ERGs. There was bilateral P50 reduction in one patient with unilateral PPCRA (Case 16).
Serial ERG testing in cases 1, 8, 17, and 21 over periods of 2, 10, 14, and 15 years, respectively, revealed a high degree of stability in both eyes (see Figure 5B , Supplemental Digital Content 5, http:// links.lww.com/IAE/A791).
Over the same periods, PERG P50 was stable bilaterally in Case 1, showed mild worsening in both eyes of Case 8, mild worsening in the right eye of Case 17 and in Case 21, the left eye P50 showed significant improvement after 10 years after treatment with tacrolimus.
Discussion
Pigmented paravenous chorioretinal atrophy is a rare disorder with limited published descriptions to date. We present detailed clinical and imaging data in a large cohort of 23 affected patients seen at a single center, highlighting the interocular structural and functional asymmetry and nonprogressive nature. There were no cases of families with more than one affected member consistent with an acquired rather than genetic etiology.
Most patients were visually asymptomatic and the diagnosis was based on the characteristic fundus appearance, often detected on routine eye examination. 5, 7, 8 Two-thirds of the patients in our series were asymptomatic. Those with symptoms presented with complaints such as flashing lights, nyctalopia, and loss of peripheral vision and showed more severe retinal changes. The average age at diagnosis was 36 years, the youngest being 10 years of age in our series, with no sex predilection.
The underlying basis of PPCRA is controversial, and includes genetic and postinflammatory etiologies. 1, 10 McKay et al reported a heterozygous CRB1 variant of uncertain significance identified in a family with apparently dominantly inherited PPCRA with variable expressivity. This variant was identified using Sanger sequencing of a positional candidate gene. It is feasible that this is not the causative variant and further investigation of the family using next generation sequencing may highlight another causative gene. 18 Obata et al 1 described PPCRA in two Japanese siblings with different manifestation, where the brother was more affected than the sister. Others have proposed degenerative, 6 developmental, 19 vascular, or congenital etiologies. 12 Previous infection/inflammation has been proposed previously as causative including Tuberculous, congenital syphilis, Behcet disease, measles, and rubella. 8, 20, 21 Murray 7 reported a 17-year-old white female who developed PPCRA after an episode of retinal swelling but no intraocular inflammation with resultant poor visual outcome after 20 years of follow-up. One child in our series similarly developed PPCRA after retinal edema and optic neuritis that occurred after MMR vaccination. Slowly progressive PPCRA-like changes in two middle-aged women with active bilateral panuveitis of several years 526 RETINA, THE JOURNAL OF RETINAL AND VITREOUS DISEASES 2019 VOLUME 39 NUMBER 3 duration of unknown etiology have also been described. 20, 22 The role of inflammation remains unclear, but interestingly, patient 17 in our series developed PPCRA in the same eye that had previous active intraocular inflammation secondary to TB. However, it was not possible to ascertain if the PPCRA changes were present before the ocular inflammation because both were discovered simultaneously. Another patient (21) with intermediated uveitis treated with prednisolone and mycophenolate mofetil for 10 years showed improvement clinically and on PERG after additional 9 months course of tacrolimus. Human leukocyte antigen A29 and antiretinal antibodies were negative. There are no previous reports of an association with immunization. Patient 4 who developed flu-like symptoms, retinal edema, and reduced vision 3 weeks after MMR immunization, was subsequently noted to have bilateral PPCRA. This raises the possibility of a postinflammatory mechanism, given the association between inflammatory disease, including optic neuritis, and various vaccinations. [23] [24] [25] Several authors have attempted to classify PPCRA based on natural history, presumed etiology (primary or secondary such as postinflammatory), 20, 22, 26 and/or severity (mild, moderate, and severe). In our cohort, the fundus appearance was variable-ranging from mild retinal changes including pigment clumps, chorioretinal paravenular disturbance, and sparing of the peripapillary region; to increasingly prominent retinal disturbance and peripapillary involvement ("severe" PPCRA). Of note, we only observed progression in one patient over a 10-year period. The macula is seldom clinically involved thereby accounting for the often good visual acuity-although there was evidence of macular disturbance on spectral domain OCT in 14/ 18 (88%) patients in our cohort. Despite these OCT changes, most (86%) retained a visual acuity $6/12 at final follow-up.
Normal optic disks and retinal vessel caliber is commonly observed in PPCRA as noted in our series in 90% of our patients, in direct contrast with RP. Macular changes including cystoid macular edema (CMO) and/or epiretinal membrane are common in RP, occurring in approximately 20% of patients with RP. 27 Mild CMO was noted in only one patient in our cohort who had extensive chorioretinal changes-with CMO resolution without treatment after 3 years. There is no previous documentation of CMO in PPCRA in the literature, the pathogenesis of which might be similar to CMO in RP. 28, 29 In all patients, FAF changes were more obvious and extended to the periphery beyond the clinically evident paravenous chorioretinal changes. In some "milder" cases, only hypoautofluorescence was evident rather than additional surrounding increased signal. Spectral domain OCT imaging over the PPCRA lesions has shown thinning of the choroidal, RPE, outer retinal, 8 and inner retinal layers. 30 The RPE may be the primary layer affected given the aforementioned hypoautofluorescence. However, Barteselli 31 demonstrated choroidal thinning in a 25-year-old Japanese with early PPCRA, in areas where RPE was unaffected associated with visible overlying thinning of the entire outer retina, suggesting that in the early/mild stages of PPCRA choroidal thinning precedes development of definite RPE atrophy. It was hypothesized that decreased choroidal perfusion secondary to choroidal thinning may lead to insufficient metabolic supply for the outer retinal structures leading to thinning and atrophy of the photoreceptors first and then the RPE later. By contrast, Ahmed et al 32 showed a thickened cystic retinal nerve fiber layer on spectral domain OCT in a 79-year-old woman with uniocular PPCRA which they believed supported a vascular etiology rather than an RPE-based cause. We found no such changes in our series.
Previously reported visual field findings have ranged from normal to severe constriction-often associated with the severity of observed retinal changes, and usually corresponding to the areas of retinal atrophy. 22, 33 In our cohort, perimetry was performed in only 7 cases and ranged from normal, to enlarged blind spot, to peripheral visual field defects. We did not observe a definite progression in visual field loss over time in our cohort.
A wide range of ERG abnormalities have been documented in PPRCA, from normal to undetectable responses, 8 but mostly using older or nonstandard ERG methods. In our series, ISCEV-standard full-field ERGs in most showed evidence of generalized retinal dysfunction with a similar degree of rod and cone system involvement, and significant interocular ERG asymmetry was common. Generalized photoreceptor dysfunction occurred in the majority, but some showed evidence of additional or predominant inner retinal dysfunction. By contrast, patients with RP typically have ERG evidence of predominant rod photoreceptor dysfunction (rod-cone dystrophy), with a high degree of interocular symmetry. One patient (Case 21) had evidence of generalized inner retinal dysfunction affecting rod and cone On-bipolar function. Similar but more severe On-bipolar dysfunction may be associated with melanoma-associated retinopathy and some cases of presumed autoimmune retinopathy [34] [35] [36] and it is tempting to speculate a postinflammatory or autoimmune etiology. There are isolated accounts of PERG findings in PPCRA including reports of absent PPCRA-DETAILED CLINICAL STUDY SHONA ET AL 527 responses 7 and PERG N95 loss, suggesting retinal ganglion cell dysfunction. 22 In our series, there was a high incidence of PERG P50 reduction, varying in severity and including cases of unilateral and asymmetrical macular dysfunction. It is notable that EOG abnormality was broadly in keeping with DA ERG a-wave reduction, suggesting generalized dysfunction of the photoreceptor/RPE interface rather than primary or selective generalized RPE dysfunction, as it has been reported in some other forms of asymmetrical retinopathy such as acute zonal occult outer retinopathy. 37 Our study has several inherent limitations given its retrospective nature, with other weaknesses including the limited visual field data. It has many strengths including being a large series, with high-quality multimodal imaging and ISCEV-standard ERGs in most patients, and serial assessments over time.
In this large series of patients with PPCRA, we show that most patients with PPCRA retain stable vision over time, with minimal if any definite evidence of structural or functional progression. There was no strong evidence of a genetic basis and we observed that interocular structural and functional asymmetry is common.
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